Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
11
CDT Quote, Financials, Valuation and Earnings
Last price:
$2.21
Seasonality move
:
-51.38%
Day range:
$2.13 - $2.27
52-week range:
$2.13 - $622.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.65x
Volume:
149.1K
Avg. volume:
589.6K
1-year change:
-99.42%
Market cap:
$1.7M
Revenue:
--
EPS (TTM):
-$237.75
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $283K | $111K | $90K | $3.4M | |
| Selling, General & Admin | -- | $2.9M | $3M | $5.2M | $12M | |
| Other Inc / (Exp) | -- | -$484K | -$1.7M | $8.3M | -$1.2M | |
| Operating Expenses | -- | $3.2M | $3.2M | $5.3M | $15.1M | |
| Operating Income | -- | -$3.2M | -$3.2M | -$5.3M | -$15.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$3.7M | -$4.9M | $2.8M | -$17.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$3.7M | -$4.9M | -$535K | -$17.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$3.7M | -$4.9M | -$535K | -$17.8M | |
| Basic EPS (Cont. Ops) | -- | -$75.75 | -$101.23 | -$11.85 | -$307.95 | |
| Diluted EPS (Cont. Ops) | -- | -$75.75 | -$101.23 | -$133.80 | -$307.95 | |
| Weighted Average Basic Share | -- | $48.3K | $48.3K | $44.7K | $57.8K | |
| Weighted Average Diluted Share | -- | $48.3K | $48.3K | $45.3K | $57.8K | |
| EBITDA | -- | -$3.2M | -$4.9M | $3.1M | -$15.8M | |
| EBIT | -- | -$3.2M | -$4.9M | $3.1M | -$16.3M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$3.2M | -$3.2M | -$5.3M | -$15.1M | |
| Operating Income (Adjusted) | -- | -$3.2M | -$4.9M | $3.1M | -$16.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $128K | $1.3M | |
| Selling, General & Admin | -- | $291K | $1.5M | $2.8M | $2.7M | |
| Other Inc / (Exp) | -- | -$16K | -$157K | -$487K | -$969K | |
| Operating Expenses | -- | $291K | $1.5M | $3M | $4M | |
| Operating Income | -- | -$291K | -$1.5M | -$3M | -$4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$307K | -$1.7M | -$3.6M | -$5.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$307K | -$1.7M | -$3.6M | -$5.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$307K | -$1.7M | -$3.6M | -$5.1M | |
| Basic EPS (Cont. Ops) | -- | -$6.36 | -$34.63 | -$72.15 | -$19.80 | |
| Diluted EPS (Cont. Ops) | -- | -$6.36 | -$34.63 | -$72.15 | -$19.80 | |
| Weighted Average Basic Share | -- | $48.3K | $48.3K | $49.2K | $259.1K | |
| Weighted Average Diluted Share | -- | $48.3K | $48.3K | $49.2K | $259.1K | |
| EBITDA | -- | -$307K | -$1.7M | -$3.4M | -$4.8M | |
| EBIT | -- | -$307K | -$1.7M | -$3.4M | -$5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$291K | -$1.5M | -$3M | -$4M | |
| Operating Income (Adjusted) | -- | -$307K | -$1.7M | -$3.4M | -$5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $218K | $4.6M | |
| Selling, General & Admin | -- | -- | $4.3M | $6.5M | $11.9M | |
| Other Inc / (Exp) | -- | -$16K | -$1.6M | $7.9M | -$1.7M | |
| Operating Expenses | -- | -- | $4.4M | $6.7M | $16.2M | |
| Operating Income | -- | -- | -$4.4M | -$6.7M | -$16.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$6M | $963K | -$19.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -$2.4M | -$19.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$6M | -$2.4M | -$19.4M | |
| Basic EPS (Cont. Ops) | -- | -- | -$124.40 | -$44.90 | -$237.75 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$124.40 | -$136.85 | -$237.75 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$6M | $1.2M | -$17.2M | |
| EBIT | -- | -- | -$6M | $1.2M | -$17.8M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$4.4M | -$6.7M | -$16.2M | |
| Operating Income (Adjusted) | -- | -- | -$6M | $1.2M | -$17.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $128K | $1.3M | |
| Selling, General & Admin | -- | $291K | $1.5M | $2.8M | $2.7M | |
| Other Inc / (Exp) | -- | -$16K | -$157K | -$487K | -$969K | |
| Operating Expenses | -- | $291K | $1.5M | $3M | $4M | |
| Operating Income | -- | -$291K | -$1.5M | -$3M | -$4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$307K | -$1.7M | -$3.6M | -$5.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$307K | -$1.7M | -$3.6M | -$5.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$307K | -$1.7M | -$3.6M | -$5.1M | |
| Basic EPS (Cont. Ops) | -- | -$6.36 | -$34.63 | -$72.15 | -$19.80 | |
| Diluted EPS (Cont. Ops) | -- | -$6.36 | -$34.63 | -$72.15 | -$19.80 | |
| Weighted Average Basic Share | -- | $48.3K | $48.3K | $49.2K | $259.1K | |
| Weighted Average Diluted Share | -- | $48.3K | $48.3K | $49.2K | $259.1K | |
| EBITDA | -- | -$307K | -$1.7M | -$3.4M | -$4.8M | |
| EBIT | -- | -$307K | -$1.7M | -$3.4M | -$5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$291K | -$1.5M | -$3M | -$4M | |
| Operating Income (Adjusted) | -- | -$307K | -$1.7M | -$3.4M | -$5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $4.2M | $554K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $1.5M | $1.7M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | $5.7M | $2.7M | |
| Property Plant And Equipment | -- | -- | -- | -- | $303K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $5K | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | $1.5M | $1.2M | |
| Total Assets | -- | -- | $5K | $7.2M | $4.2M | |
| Accounts Payable | -- | -- | -- | $215K | $1.4M | |
| Accrued Expenses | -- | $2.2M | $2.6M | $601K | $2M | |
| Current Portion Of Long-Term Debt | -- | -- | $175K | $800K | $6.7M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $119K | |
| Other Current Liabilities | -- | $6K | $1.4M | -- | -- | |
| Total Current Liabilities | -- | $2.2M | $4.2M | $1.8M | $10.7M | |
| Long-Term Debt | -- | $749K | $1.8M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $5.9M | $10.1M | $7.7M | $11M | |
| Common Stock | -- | -- | $6K | $7K | $14K | |
| Other Common Equity Adj | -- | -$65K | $675K | $411K | $414K | |
| Common Equity | -- | -$5.9M | -$10.1M | -$457K | -$6.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -$5.9M | -$10.1M | -$457K | -$6.8M | |
| Total Liabilities and Equity | -- | -- | $5K | $7.2M | $4.2M | |
| Cash and Short Terms | -- | -- | -- | $4.2M | $554K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $8K | $1.8M | $2.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $1.2M | $3.3M | |
| Other Current Assets | -- | -- | -- | $114K | -- | |
| Total Current Assets | -- | -- | $8K | $3.2M | $5.9M | |
| Property Plant And Equipment | -- | -- | -- | $346K | $275K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $5K | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | $1.4M | $1.1M | |
| Total Assets | -- | -- | $13K | $4.9M | $7.3M | |
| Accounts Payable | -- | -- | -- | $117K | $714K | |
| Accrued Expenses | -- | -- | $2.4M | $743K | $972K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $800K | $2.7M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $141K | $126K | |
| Other Current Liabilities | -- | -- | $1.3M | -- | $15K | |
| Total Current Liabilities | -- | -- | $3.8M | $2M | $4.5M | |
| Long-Term Debt | -- | -- | $4.6M | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $12.5M | $8M | $4.6M | |
| Common Stock | -- | -- | -- | $7K | $19K | |
| Other Common Equity Adj | -- | -- | $412K | $388K | $346K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -$12.5M | -$3.1M | $2.7M | |
| Total Liabilities and Equity | -- | -- | $13K | $4.9M | $7.3M | |
| Cash and Short Terms | -- | -- | $8K | $1.8M | $2.1M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$3.7M | -$4.9M | -$535K | -$17.8M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $457K | |
| Stock-Based Compensation | -- | -- | -- | $199K | $1.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$2.2M | -$2.3M | -$7.7M | -$9.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$183K | $725K | -$43K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $688K | $1.1M | $2.3M | $3.2M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$776K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | $8.6M | -- | |
| Cash From Financing | -- | $1.9M | $2.4M | $10.9M | $6.1M | |
| Beginning Cash (CF) | -- | $252K | -- | -- | $4.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$253K | -$1K | $3.9M | -$3.7M | |
| Ending Cash (CF) | -- | -- | -- | $4.2M | $554K | |
| Levered Free Cash Flow | -- | -$2.2M | -$2.3M | -$7.7M | -$9.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$307K | -$1.7M | -$3.6M | -$5.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $190K | |
| Stock-Based Compensation | -- | -- | -- | $431K | $234K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$788K | -$2M | -$2.4M | -$4.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$243K | -- | -$4K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $2.2M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$2.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $789K | $2.2M | -- | $5.9M | |
| Beginning Cash (CF) | -- | -- | -- | $4.2M | $554K | |
| Foreign Exchange Rate Adjustment | -- | $1K | $1K | -$27K | -$18K | |
| Additions / Reductions | -- | $1K | $7K | -$2.4M | $1.6M | |
| Ending Cash (CF) | -- | $2K | $8K | $1.8M | $2.1M | |
| Levered Free Cash Flow | -- | -$788K | -$2M | -$2.4M | -$4.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$2.4M | -$19.4M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | $630K | $1.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$8.1M | -$11.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | $968K | -$47K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $66K | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $8.7M | $12M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $1.6M | $293K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$8.1M | -$11.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$307K | -$1.7M | -$3.6M | -$5.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | $190K | |
| Stock-Based Compensation | -- | -- | -- | $431K | $234K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$788K | -$2M | -$2.4M | -$4.3M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$243K | -- | -$4K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $2.2M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$2.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $789K | $2.2M | -- | $5.9M | |
| Beginning Cash (CF) | -- | -- | -- | $4.2M | $554K | |
| Foreign Exchange Rate Adjustment | -- | $1K | $1K | -$27K | -$18K | |
| Additions / Reductions | -- | $1K | $7K | -$2.4M | $1.6M | |
| Ending Cash (CF) | -- | $2K | $8K | $1.8M | $2.1M | |
| Levered Free Cash Flow | -- | -$788K | -$2M | -$2.4M | -$4.3M | |
Get CDT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CDT
Sector
P/E ratio
--
23.88x
PEG ratio
--
0.00x
P/B ratio
0.65x
1.80x
Price / LTM sales
--
1.65x
Growth Metrics
CDT
Sector
Revenue growth
--
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
--
8.01%
Earnings forecast
--
-$0.20
Profitability
CDT
Sector
Profitability FY 2025
--
$47.5M
Return on invested capital
--
-16.26%
Return on assets
--
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
15
Next Earnings Date
Aug
12
Estimated Next Earnings Date
Aug
14
Balance Sheet
CDT
Sector
Total cash
$2.1M
$35.5M
Short term investments
--
$29.7M
Total assets
$4.2M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
